📰 ET Markets 🟢 BULLISH 🕒 27 Oct 2026, 07:30 AM IST

Mankind Pharma Q2 profit rises 38% to Rs 716 crore

⚡ Instant Key Takeaways (TL;DR)

🎯

Core Development: Mankind Pharma Q2 profit rises 38% to Rs 716 crore

📊

Market & Financial Impact: Mankind Pharma has announced a profit increase of 37.7% to ₹716 crore during the September quarter. Revenue from operations rose to ₹4,337.9 crore compared to ₹3,697.2 crore in the same quarter last year. This growth is attributed to strong performance in both domestic and international markets. The recent acquisition of Armed Cell Therapeutics is expected to enhance R&D capabilities.

💡

Actionable Insight: 🟢 Bullish Trigger: Positive business expansion or earnings beat may attract institutional and retail buying.

Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

Will oil turn into a lingering problem? Is the world economy, India, or the market prepared?

KYB and KYC: Business behind the wealth creator called ‘Divi’s Lab’ – Part 2, concluding

KYB and KYC: Business behind the wealth creator called “Divi’s Lab” – Part 1

📰

Official Publisher Attribution: This report is aggregated from Economic Times. ZeroLive provides live aggregation, automated sentiment synthesis, and exchange disclosure monitoring for retail market participants.

Read Original Full Coverage on Economic Times ↗

⚡

Get Breaking Stock Alerts & Q-Results on Telegram

Real-time 1200x675 image cards and financial filings delivered instantly.

Join @Zerolive_news ↗

Mankind Pharma Q2 profit rises 38% to Rs 716 crore

🔥 More Live Market Stories

Trade Spotlight: How should you trade BSE, Mankind Pharma, Bajaj Finserv, Bharti Airtel, Zydus Lifesciences, and others on October 27?

Chart of the Day: Does RBI play in forex market to curb volatility or target a rupee level?

Indian shares seen lower as oil stays near six-month high, Fed in focus

Margin funding book sees highest liquidation in a day

Earnings call transcript: Sandfire Resources posts strong Q1 2026 start

GIFT Nifty falls 100 pts, signals weak start for Sensex, Nifty despite Asian, Wall Street rallies; Fed in focus